Medicure (MCUJF) Preferred Stock Liabilities (2009 - 2011)
Medicure's (MCUJF) quarterly Preferred Stock Liabilities came in at $5.7 million in Q1 2011, down 6.8% year-on-year from $6.2 million in Q1 2010, and up 6.7% quarter-over-quarter from $5.4 million in Q4 2010.
Medicure (MCUJF) Preferred Stock Liabilities (2009 - 2011) Analysis & Trends
Medicure's Preferred Stock Liabilities history runs 3 years deep, the most recent figure standing at $5.7 million for Q1 2011.
- On a quarterly basis, Preferred Stock Liabilities fell 6.8% year-over-year to $5.7 million in Q1 2011; TTM through Feb 2011 was $5.7 million, a 6.8% decrease from a year earlier, with the FY2010 full-year figure at $5.6 million, down 32.34% from the prior year.
- Preferred Stock Liabilities improved to $5.7 million in Q1 2011 per MCUJF's latest filing, from $5.4 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $7.9 million in Q2 2009 and bottomed at $5.4 million in Q4 2010.
- The 3-year median for Preferred Stock Liabilities is $6.0 million (2010), against an average of $6.4 million.
- Across the five-year window, Preferred Stock Liabilities decreased 29.84% in 2010 and declined 6.8% in 2011, its largest moves.
- Year by year, Preferred Stock Liabilities stood at $7.4 million in 2009, then slipped by 27.06% to $5.4 million in 2010, then grew by 6.7% to $5.7 million in 2011.
- Per Business Quant, the three latest MCUJF Preferred Stock Liabilities figures stand at $5.7 million (Q1 2011), $5.4 million (Q4 2010), and $5.4 million (Q3 2010).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2011 | 5.74 Mn |
| Nov 30, 2010 | 5.38 Mn |
| Aug 31, 2010 | 5.38 Mn |
| May 31, 2010 | 5.84 Mn |
| Feb 28, 2010 | 6.16 Mn |
| Nov 30, 2009 | 7.37 Mn |
| Aug 31, 2009 | 7.67 Mn |
| May 31, 2009 | 7.89 Mn |